TY  - GEN
AU  - Osterborg,A
AU  - Werner,A
AU  - Halapi,E
AU  - Lundin,J
AU  - Harmenberg,U
AU  - Wigzell,H
AU  - Mellstedt,H
TI  - Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52)
SN  - 0902-4441
PY  - 1997///0228
KW  - Adult
KW  - Aged
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, Neoplasm
KW  - Antineoplastic Agents
KW  - B-Lymphocytes
KW  - CD52 Antigen
KW  - CD8-Positive T-Lymphocytes
KW  - Female
KW  - Glycoproteins
KW  - Humans
KW  - Immunity, Cellular
KW  - drug effects
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - drug therapy
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Middle Aged
KW  - T-Lymphocyte Subsets
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1600-0609.1997.tb01403.x
ER  -